Amparo Burgos-San José, Claudia Colomer-Aguilar, Daniel Martínez-Caballero, & Bartomeu Massutí-Sureda. (2021). Effectiveness and safety of atezolizumab, nivolumab and pembrolizumab in metastatic non-small cell lung cancer. Elsevier.
Chicago Style (17th ed.) CitationAmparo Burgos-San José, Claudia Colomer-Aguilar, Daniel Martínez-Caballero, and Bartomeu Massutí-Sureda. Effectiveness and Safety of Atezolizumab, Nivolumab and Pembrolizumab in Metastatic Non-small Cell Lung Cancer. Elsevier, 2021.
MLA (9th ed.) CitationAmparo Burgos-San José, et al. Effectiveness and Safety of Atezolizumab, Nivolumab and Pembrolizumab in Metastatic Non-small Cell Lung Cancer. Elsevier, 2021.
Warning: These citations may not always be 100% accurate.